Green Cures Botanical Stock Retained Earnings
GRCU Stock | USD 0.0001 0.0001 50.00% |
Green Cures Botanical fundamentals help investors to digest information that contributes to Green Cures' financial success or failures. It also enables traders to predict the movement of Green Pink Sheet. The fundamental analysis module provides a way to measure Green Cures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Green Cures pink sheet.
Green |
Green Cures Botanical Company Retained Earnings Analysis
Green Cures' Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Green Cures Retained Earnings | (1.58 M) |
Most of Green Cures' fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Green Cures Botanical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Green Cures Botanical has a Retained Earnings of (1.58 Million). This is 100.17% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The retained earnings for all United States stocks is 100.02% higher than that of the company.
Green Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Green Cures' direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Green Cures could also be used in its relative valuation, which is a method of valuing Green Cures by comparing valuation metrics of similar companies.Green Cures is currently under evaluation in retained earnings category among related companies.
Green Fundamentals
Return On Equity | 0.55 | |||
Return On Asset | 0.023 | |||
Profit Margin | 4.96 % | |||
Operating Margin | 0.62 % | |||
Current Valuation | 4.85 M | |||
Price To Sales | 2.80 X | |||
Revenue | 13.17 K | |||
Gross Profit | 989.6 K | |||
EBITDA | 861.7 K | |||
Net Income | (1.09 M) | |||
Cash And Equivalents | 80 K | |||
Cash Per Share | 0.04 X | |||
Total Debt | 3.1 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 4.85 X | |||
Book Value Per Share | (2.23) X | |||
Cash Flow From Operations | (73.09 K) | |||
Earnings Per Share | 3.15 X | |||
Number Of Employees | 20 | |||
Beta | 1.09 | |||
Market Capitalization | 2.54 M | |||
Total Asset | 406 | |||
Retained Earnings | (1.58 M) | |||
Working Capital | (539 K) | |||
Current Liabilities | 539 K | |||
Z Score | -22.03 | |||
Net Asset | 406 |
About Green Cures Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Green Cures Botanical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Green Cures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Green Cures Botanical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Green Cures in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Green Cures' short interest history, or implied volatility extrapolated from Green Cures options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Green Cures Botanical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Green Cures Botanical information on this page should be used as a complementary analysis to other Green Cures' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Green Pink Sheet analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |